Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Apr 1;101(7):1490–1499. doi: 10.1172/JCI1976

A nonsense mutation in the carboxyl-terminal domain of type X collagen causes haploinsufficiency in schmid metaphyseal chondrodysplasia.

D Chan 1, Y M Weng 1, H K Graham 1, D O Sillence 1, J F Bateman 1
PMCID: PMC508727  PMID: 9525992

Abstract

Type X collagen is a short-chain homotrimeric collagen expressed in the hypertrophic zone of calcifying cartilage. The clustering of mutations in the carboxyl-terminal NC1 domain in Schmid metaphyseal chondrodysplasia (SMCD) suggested a critical role for this type X collagen domain, but since no direct analysis of cartilage has been conducted in SMCD patients, the mechanisms of type X collagen dysfunction remain controversial. To resolve this problem, we obtained SMCD growth plate cartilage, determined the type X collagen mutation, and analyzed the expression of mutant and normal type X collagen mRNA and protein. The mutation was a single nucleotide substitution that changed the Tyr632 codon (TAC) to a stop codon (TAA). However, analysis of the expression of the normal and mutant allele transcripts in growth plate cartilage by reverse transcription PCR, restriction enzyme mapping, and a single nucleotide primer extension assay, demonstrated that only normal mRNA was present. The lack of mutant mRNA is most likely the result of nonsense-mediated mRNA decay, a common fate for transcripts carrying premature termination mutations. Furthermore, no mutant protein was detected by immunoblotting cartilage extracts. Our data indicates that a functionally null allele leading to type X collagen haploinsufficiency is the molecular basis of SMCD in this patient.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apte S. S., Olsen B. R. Characterization of the mouse type X collagen gene. Matrix. 1993 Mar;13(2):165–179. doi: 10.1016/s0934-8832(11)80075-2. [DOI] [PubMed] [Google Scholar]
  2. Bateman J. F., Chan D., Mascara T., Rogers J. G., Cole W. G. Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J. 1986 Dec 15;240(3):699–708. doi: 10.1042/bj2400699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bateman J. F., Golub S. B. Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro. Matrix Biol. 1994 Apr;14(3):251–262. doi: 10.1016/0945-053x(94)90189-9. [DOI] [PubMed] [Google Scholar]
  4. Bateman J. F., Lamande S. R., Dahl H. H., Chan D., Mascara T., Cole W. G. A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta. J Biol Chem. 1989 Jul 5;264(19):10960–10964. [PubMed] [Google Scholar]
  5. Bateman J. F., Mascara T., Chan D., Cole W. G. Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J. 1984 Jan 1;217(1):103–115. doi: 10.1042/bj2170103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brass A., Kadler K. E., Thomas J. T., Grant M. E., Boot-Handford R. P. The fibrillar collagens, collagen VIII, collagen X and the C1q complement proteins share a similar domain in their C-terminal non-collagenous regions. FEBS Lett. 1992 Jun 1;303(2-3):126–128. doi: 10.1016/0014-5793(92)80503-9. [DOI] [PubMed] [Google Scholar]
  7. Carter M. S., Doskow J., Morris P., Li S., Nhim R. P., Sandstedt S., Wilkinson M. F. A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem. 1995 Dec 1;270(48):28995–29003. doi: 10.1074/jbc.270.48.28995. [DOI] [PubMed] [Google Scholar]
  8. Chan D., Cole W. G., Rogers J. G., Bateman J. F. Type X collagen multimer assembly in vitro is prevented by a Gly618 to Val mutation in the alpha 1(X) NC1 domain resulting in Schmid metaphyseal chondrodysplasia. J Biol Chem. 1995 Mar 3;270(9):4558–4562. doi: 10.1074/jbc.270.9.4558. [DOI] [PubMed] [Google Scholar]
  9. Chan D., Weng Y. M., Hocking A. M., Golub S., McQuillan D. J., Bateman J. F. Site-directed mutagenesis of human type X collagen. Expression of alpha1(X) NC1, NC2, and helical mutations in vitro and in transfected cells. J Biol Chem. 1996 Jun 7;271(23):13566–13572. doi: 10.1074/jbc.271.23.13566. [DOI] [PubMed] [Google Scholar]
  10. Cotton R. G., Rodrigues N. R., Campbell R. D. Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4397–4401. doi: 10.1073/pnas.85.12.4397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Douglas A. M., Georgalis A. M., Benton L. R., Canavan K. L., Atchison B. A. Purification of human leucocyte DNA: proteinase K is not necessary. Anal Biochem. 1992 Mar;201(2):362–365. doi: 10.1016/0003-2697(92)90352-8. [DOI] [PubMed] [Google Scholar]
  12. Gibson G. J., Francki K. T., Hopwood J. J., Foster B. K. Human and sheep growth-plate cartilage type X collagen synthesis and the influence of tissue storage. Biochem J. 1991 Jul 15;277(Pt 2):513–520. doi: 10.1042/bj2770513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Grant W. T., Wang G. J., Balian G. Type X collagen synthesis during endochondral ossification in fracture repair. J Biol Chem. 1987 Jul 15;262(20):9844–9849. [PubMed] [Google Scholar]
  14. Jacenko O., LuValle P. A., Olsen B. R. Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition. Nature. 1993 Sep 2;365(6441):56–61. doi: 10.1038/365056a0. [DOI] [PubMed] [Google Scholar]
  15. Kielty C. M., Kwan A. P., Holmes D. F., Schor S. L., Grant M. E. Type X collagen, a product of hypertrophic chondrocytes. Biochem J. 1985 Apr 15;227(2):545–554. doi: 10.1042/bj2270545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kwan K. M., Pang M. K., Zhou S., Cowan S. K., Kong R. Y., Pfordte T., Olsen B. R., Sillence D. O., Tam P. P., Cheah K. S. Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function. J Cell Biol. 1997 Jan 27;136(2):459–471. doi: 10.1083/jcb.136.2.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lachman R. S., Rimoin D. L., Spranger J. Metaphyseal chondrodysplasia, Schmid type. Clinical and radiographic delineation with a review of the literature. Pediatr Radiol. 1988;18(2):93–102. doi: 10.1007/BF02387549. [DOI] [PubMed] [Google Scholar]
  18. Lamandé S. R., Chessler S. D., Golub S. B., Byers P. H., Chan D., Cole W. G., Sillence D. O., Bateman J. F. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly. J Biol Chem. 1995 Apr 14;270(15):8642–8649. doi: 10.1074/jbc.270.15.8642. [DOI] [PubMed] [Google Scholar]
  19. LuValle P., Ninomiya Y., Rosenblum N. D., Olsen B. R. The type X collagen gene. Intron sequences split the 5'-untranslated region and separate the coding regions for the non-collagenous amino-terminal and triple-helical domains. J Biol Chem. 1988 Dec 5;263(34):18378–18385. [PubMed] [Google Scholar]
  20. Maquat L. E. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA. 1995 Jul;1(5):453–465. [PMC free article] [PubMed] [Google Scholar]
  21. Mashima Y., Murakami A., Weleber R. G., Kennaway N. G., Clarke L., Shiono T., Inana G. Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet. 1992 Jul;51(1):81–91. [PMC free article] [PubMed] [Google Scholar]
  22. McIntosh I., Hamosh A., Dietz H. C. Nonsense mutations and diminished mRNA levels. Nat Genet. 1993 Jul;4(3):219–219. doi: 10.1038/ng0793-219. [DOI] [PubMed] [Google Scholar]
  23. Mundlos S., Chan D., Weng Y. M., Sillence D. O., Cole W. G., Bateman J. F. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix. J Biol Chem. 1996 Aug 30;271(35):21068–21074. doi: 10.1074/jbc.271.35.21068. [DOI] [PubMed] [Google Scholar]
  24. Nerlich A. G., Kirsch T., Wiest I., Betz P., von der Mark K. Localization of collagen X in human fetal and juvenile articular cartilage and bone. Histochemistry. 1992 Dec;98(5):275–281. doi: 10.1007/BF00270010. [DOI] [PubMed] [Google Scholar]
  25. Reichenberger E., Aigner T., von der Mark K., Stöss H., Bertling W. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Dev Biol. 1991 Dec;148(2):562–572. doi: 10.1016/0012-1606(91)90274-7. [DOI] [PubMed] [Google Scholar]
  26. Reichenberger E., Beier F., LuValle P., Olsen B. R., von der Mark K., Bertling W. M. Genomic organization and full-length cDNA sequence of human collagen X. FEBS Lett. 1992 Oct 26;311(3):305–310. doi: 10.1016/0014-5793(92)81126-7. [DOI] [PubMed] [Google Scholar]
  27. Rosati R., Horan G. S., Pinero G. J., Garofalo S., Keene D. R., Horton W. A., Vuorio E., de Crombrugghe B., Behringer R. R. Normal long bone growth and development in type X collagen-null mice. Nat Genet. 1994 Oct;8(2):129–135. doi: 10.1038/ng1094-129. [DOI] [PubMed] [Google Scholar]
  28. Schmid T. M., Linsenmayer T. F. A short chain (pro)collagen from aged endochondral chondrocytes. Biochemical characterization. J Biol Chem. 1983 Aug 10;258(15):9504–9509. [PubMed] [Google Scholar]
  29. Sillence D. O., Horton W. A., Rimoin D. L. Morphologic studies in the skeletal dysplasias. Am J Pathol. 1979 Sep;96(3):813–870. [PMC free article] [PubMed] [Google Scholar]
  30. Thomas J. T., Cresswell C. J., Rash B., Nicolai H., Jones T., Solomon E., Grant M. E., Boot-Handford R. P. The human collagen X gene. Complete primary translated sequence and chromosomal localization. Biochem J. 1991 Dec 15;280(Pt 3):617–623. doi: 10.1042/bj2800617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wallis G. A., Rash B., Sykes B., Bonaventure J., Maroteaux P., Zabel B., Wynne-Davies R., Grant M. E., Boot-Handford R. P. Mutations within the gene encoding the alpha 1 (X) chain of type X collagen (COL10A1) cause metaphyseal chondrodysplasia type Schmid but not several other forms of metaphyseal chondrodysplasia. J Med Genet. 1996 Jun;33(6):450–457. doi: 10.1136/jmg.33.6.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Warman M. L., Abbott M., Apte S. S., Hefferon T., McIntosh I., Cohn D. H., Hecht J. T., Olsen B. R., Francomano C. A. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet. 1993 Sep;5(1):79–82. doi: 10.1038/ng0993-79. [DOI] [PubMed] [Google Scholar]
  33. Willing M. C., Deschenes S. P., Slayton R. L., Roberts E. J. Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet. 1996 Oct;59(4):799–809. [PMC free article] [PubMed] [Google Scholar]
  34. Zhang Z. X., Wakamatsu N., Mules E. H., Thomas G. H., Gravel R. A. Impact of premature stop codons on mRNA levels in infantile Sandhoff disease. Hum Mol Genet. 1994 Jan;3(1):139–145. doi: 10.1093/hmg/3.1.139. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES